Clinical Trial Update: Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating OZ439 as a gametocytocidal and transmission-blocking agent for malaria; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• OZ439

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-26